Pcas
Net sales as of June 30, 2023
Ecully, July 27, 2023
NET SALES AS OF JUNE 30, 2023
PCAS (Euronext Paris: PCA), a specialist in developing and producing complex molecules for life sciences and innovative technologies, has announced the publication of its consolidated net sales as of June 30, 2023.
The PCAS Group has generated consolidated net sales of €113.4 million as of June 30, 2023, a 3.3% increase compared to the same period during the previous financial year (+2.9% at constant exchange rates).
In millions of euros | 2023 | 2022 | % change | 2023 At a constant exchange rate | % change | |||||
Sales as of 30 June | 113.4 | 109.8 | 3.3% | 113.0 | 2.9% | |||||
Pharmaceutical Synthesis | 68.8 | 67.4 | 2.0% | 68.6 | 1.7% | |||||
Fine Specialty Chemicals | 44.7 | 42.4 | 5.4% | 44.4 | 4.7% |
in millions of euros | France | Other areas | Total |
Net Sales by origin | |||
June 30, 2023 | 80.0 | 33.4 | 113.4 |
June 30, 2022 | 84.6 | 25.2 | 109.8 |
Lesen Sie auch
Aktuelle Themen
Weitere Artikel des Autors
1 im Artikel enthaltener WertIm Artikel enthaltene Werte